Álvaro Abad

Álvaro Abad

Associate, Madrid

Email alvaro.abad@​hoganlovells.com

Phone +34 91 349 82 00

Fax +34 91 349 82 01

LanguagesEnglish, Spanish

Practice groupRegulatory

As an associate lawyer of the Government Regulatory practice at Hogan Lovells Madrid and, in particular, of the Life Sciences Regulatory team, his position to advise Life Sciences companies from a legal perspective is quite reliable: his deep knowledge of the industry, as well as of the regulatory framework across all relevant legal areas (clinical trials, early access schemes, advertising and promotion, pricing and reimbursement, compliance, etc.), and his capacity to assimilate and digest all the technical information of the products offered by healthcare, pharma, biotech, and medical device companies, provide Álvaro with all the relevant tools to clearly understand the business pressures, needs, concerns, and issues, and come up with agile, well-founded and business-oriented solutions.

He also has extensive experience in other regulated sectors, such as food, automotive, environment, or transportation, as well as on public procurement, advising on food labeling and nutrition and health claims; type approval, vehicle registration, and autonomous driving; sanctioning proceedings relating to environmental matters; processing of transport authorizations; or on the re-establishment of economic and financial balance of public contracts.

Álvaro has also been involved in M&A transactions advising on regulatory, life sciences and environmental aspects.

Education and admissions

Education

Degree in Law and Business Administration, Francisco de Vitoria University, 2013

Master in Human and Professional Leadership, Francisco de Vitoria University, 2013

Memberships

Madrid Bar Association

Representative experience

Advising a leading pharma and biotech company on the recall of the active pharmaceutical ingredient (API) Valsatan.

Advising leading pharma companies on the launch of generic and hybrid products which jeopardize the marketing of its medicinal products.

Advising an oncology-focused biopharmaceutical company with regulatory issues on early access/compassionate use programs.

Advising a pharma company focused on developing small molecule drugs that slow tumor growth on a number of aspects relating to clinical trials conducted in Spain.

Advising several medical device companies on the launching of new and innovative medical devices.

Advising a leading tech company on the regulatory framework in Spain relating to the automotive sector and, in particular, to autonomous driving.

Advising a leading manufacturer in the automotive sector on type approval, vehicle registration, and idling provisions in Spain.

Advising a leading trade retailer on regulatory matters regarding the transport of goods.

Loading data